Last $14.34 USD
Change Today -0.78 / -5.16%
Volume 19.9K
As of 8:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Todd C. Brady M.D., Ph.D.

Chief Executive Officer, President and Director, Aldeyra Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 79 board members in 11 different organizations across 12 different industries.

See Board Relationships
42$3,687,821
As of Fiscal Year 2013

Background*

Dr. Todd C. Brady, M.D., Ph.D., serves as an Advisor to Leader Ventures since 2011, Dr. Brady has been the Chief Executive Officer and President at Aldeyra Therapeutics, Inc. since January 2012 and he also served as its Principal financial and accounting officer. He is a Co-Founder of Phenome Sciences and serves as its Chief Executive Officer. Dr. Brady serves as a Senior Advisor at Solidus Investment Co., Ltd. He was an Entrepreneur-In-Residence at Domain Associates, ...

Read Full Background

Corporate Headquarters*

46701 Commerce Center Drive
Plymouth, Michigan 48170

United States

Phone: 734-862-4840
Fax: --

Board Members Memberships*

Director
Board Observer
Director
Director
Board Observer
Board Observer
Board Observer
Director
2005-Present
Chief Executive Officer, President and Director
2006-Present
Director
2007-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

MD 1999
Duke University Medical Center
BA 1993
Dartmouth College
PhD 1998
Duke University
PhD 1998
The Graduate School, Duke University

Other Affiliations*

Annual Compensation*

Salary$70,833
Total Annual Compensation$70,833

Stock Options*

Restricted Stock Awards$136,732
Exercisable Options32,953
Unexercisable Options288,126
Total Number of Options369,100

Total Compensation*

Total Annual Cash Compensation$70,833
Total Short Term Compensation$70,833
Other Long Term Compensation$136,732
Total Calculated Compensation$3,687,821
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESPR:US $14.34 USD -0.78

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESPERION THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.